FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Granulex Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Do not use on fresh arterial clots. Avoid spraying in eyes.
Flammable, do not expose to fire or open flame. Contents under pressure.
Do not puncture or incinerate. Do not store at temperature above 120°F.
Keep out of reach of children. Use only as directed. Intentional misuse by
deliberately concentrating and inhaling the contents can be harmful or fatal.
301.3
Contents: Net weight 2 oz. (56.7g)
Inert propellant 25% of total content.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Varicose Ulcers Debride Eschar Dehiscent Wounds
Decubital Ulcers Sunburn Wound Healing
GRANULEX will relieve pain and promote healing; debrides eschar and
necrotic tissue physiologically; stimulates vascular bed; improves
epithelization by reducing premature epithelial desiccation and cornification;
reduces odor from malodorous necrotic wounds.
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Granulex Manufacturers
-
Mylan Institutional Inc.
Login To Your Free Account